Use of statins in patients with 13 different types of cancer appears to be associated with reduced cancer-related mortality when compared with no statin use, according to a Danish investigation. For statin users, the all-cause mortality and cancer-related mortality hazard ratios were 0.85 when compared with those who did not use these medications.
Abstract: New England Journal of Medicine, November 8, 2012.
